IPSC
Century TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
IPSC Profile
Century Therapeutics, Inc.
An innovative biotech company that develops induced pluripotent stem cell -derived cell therapies in immuno-oncology
Biological Technology
03/05/2018
06/18/2021
NASDAQ Stock Exchange
140
12-31
Common stock
25 N 38th Street, 11th Floor, Philadelphia, Pennsylvania 19104
--
Century Therapeutics, Inc., was incorporated in Delaware on March 5, 2018. The Company is an innovative biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of solid tumors and hematological malignancies with significant unmet medical needs. The company has created a comprehensive allogeneic cell therapy platform that includes industry-leading induced pluripotent stem cells, or iPSCs, differentiation technology to generate immune effector cells from iPSCs or iPSC-derived cells, clustered regularly spaced short palindrome repeats, or CRISPR, mediated precision gene editing that enables the integration of multiple transgenes and removal of target genes designed to optimize cell product performance, advanced protein engineering capabilities, To develop proprietary next-generation chimeric antigen receptor or CAR cell products that are influenced by the host immune system and have state-of-the-art manufacturing capabilities designed to minimize product development and supply risks.
